mtUPR is a mitochondria-to-nucleus stress signaling pathway that responds to misfolded protein accumulation in the mitochondrial matrix
The mitochondrial unfolded protein response (mtUPR) is a retrograde signaling pathway that detects proteostatic stress in the mitochondrial matrix and activates compensatory gene expression programs in the nucleus[1]. Unlike the cytosolic UPR or ER UPR, mtUPR is unique in its ability to sense mitochondrial protein misfolding and communicate this stress to the nuclear genome, activating a distinct set of protective genes[2].
mtUPR activation has been implicated in multiple neurodegenerative diseases, including Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS), making it a potential therapeutic target[3].
When misfolded proteins accumulate in the mitochondrial matrix, the mtUPR is triggered through several sensing mechanisms:
The best-characterized mtUPR signaling pathway involves:
| Protein | Function | mtUPR Role |
|---|---|---|
| ATF5 | Transcription factor | Direct target of ClpP cleavage, activates chaperone genes[7] |
| ATF4 | Translation factor | Major ISR effector, activated by eIF2α phosphorylation |
| CLPP | Protease | Sensor and signal generator[4:1] |
| mtHsp70/Hsp60 | Chaperones | First responders to misfolding[5:1] |
| CHOP | Transcription factor | Pro-apoptotic, prolonged stress |
mtUPR extensively interacts with the integrated stress response (ISR) through shared components:
Both mtUPR and other cellular stress responses converge on eIF2α phosphorylation:
All four kinases phosphorylate eIF2α at Ser51, reducing global translation while enhancing ATF4 translation.
mtUPR cross-talks with mitochondrial quality control:
mtUPR is chronically activated in AD brains[3:1]:
Evidence from human studies[8]:
PD shows specific vulnerabilities in mtUPR[9]:
Key findings[10]:
ALS features severe mtUPR activation[11]:
Evidence[12]:
Several compounds activate mtUPR:
| Compound | Mechanism | Stage |
|---|---|---|
| CC-885 | ATF4 stabilization | Preclinical |
| ISRIB | eIF2α phosphatase inhibitor | Clinical trials |
| Sodium butyrate | HDAC inhibitor, mtUPR | Research |
| Minocycline | Broad neuroprotection | Clinical trials |
mtUPR activity can be monitored through:
The mitochondrial unfolded protein response represents a critical node in cellular proteostasis that becomes dysregulated across neurodegenerative diseases. Key points:
Future research should focus on understanding cell-type-specific mtUPR regulation and developing brain-penetrant activators.
Beyond the canonical CLPP-ATF4/ATF5 pathway, alternative mtUPR signaling mechanisms exist[13]:
Mitochondrial inner membrane stress:
Mitochondrial DNA damage response:
Reactive oxygen species signaling:
Stress granules (SGs) interface with mtUPR during cellular stress:
This interface becomes disrupted in neurodegeneration, contributing to proteostasis failure.
mtUPR operates bidirectionally between neurons and glia[14]:
Neuron to astrocyte signaling:
Astrocyte to neuron signaling:
Pro-inflammatory cytokines modulate mtUPR:
This creates a feed-forward loop where neuroinflammation impairs mtUPR, leading to further dysfunction.
Microglial cells show unique mtUPR characteristics:
Targeting microglial mtUPR may modulate neuroinflammation in AD and PD.
Synaptic terminals contain specialized mitochondria with unique vulnerabilities[15]:
mtUPR activation in synaptic compartments:
mtUPR modulates synaptic plasticity:
Different neural circuits show varying mtUPR capacity:
mtUPR tightly integrates with cellular metabolism[16]:
ATP sensing: Mitochondrial ATP production rate modulates mtUPR threshold
NAD+ metabolism: SIRT1 activity depends on NAD+ levels, linking metabolism to mtUPR
Amino acid sensing: ATF4 responds to amino acid availability
Lipid metabolism: Mitochondrial lipid composition affects mtUPR
Bidirectional communication between mtUPR and mitochondrial function:
Metabolic interventions affect mtUPR:
Melber A, Haynes CM. MTUPR and the mitochondrial proteostasisome. Trends in Biochemical Sciences. 2016. ↩︎
Haynes CM, et al. mtUPR signaling coordinates mitochondrial quality control. Cell. 2007. ↩︎
Sorrentino V, et al. Mitochondrial UPR in AD. EMBO Reports. 2017. ↩︎ ↩︎
Kas V, et al. ClpP protease is a key sensor in mitochondrial UPR. Nature. 2010. ↩︎ ↩︎
Bender A, et al. Mitochondrial chaperones in neurodegeneration. Journal of Neurochemistry. 2011. ↩︎ ↩︎
Haynes CM, et al. ATF4 as a key mtUPR transcription factor. Molecular Cell. 2013. ↩︎
Fiorenza MT, et al. ATF5 function in neuronal mtUPR. Cell Death & Disease. 2015. ↩︎
Perez MJ, et al. mtUPR in AD brain. Acta Neuropathologica. 2018. ↩︎
Sato H, et al. Mitochondrial stress in PD. Journal of Neural Transmission. 2018. ↩︎
Ge P, et al. PINK1 and mtUPR. Brain. 2019. ↩︎
Pizzasecola A, et al. mtUPR in ALS. Cellular and Molecular Neurobiology. 2018. ↩︎
Taddei M, et al. ALS mitochondrial pathology. Free Radical Biology and Medicine. 2018. ↩︎
Shpilka T, Haynes CM. Mitochondrial sequence-specific UPR. Nature Communications. 2021. ↩︎
Liu J, et al. Mitochondrial UPR modulates neuroinflammation in AD. Glia. 2024. ↩︎
Du Y, et al. Mitochondrial UPR and synaptic plasticity. Neurobiology of Aging. 2021. ↩︎
Wolf DM, et al. Cellular adaptation to mitochondrial stress. Science. 2022. ↩︎